Marc de Garidel

French businessman (born 1956)

Marc de Garidel is a French Biotech Entrepreneur. He is the CEO of Abivax, a French clinical-stage, publicly traded biotechnology company (ABVX at Euronext Paris and Nasdaq Global Market), which he joined in May 2023.2

From Wikipedia’s article on Marc de Garidel (this version), CC BY-SA 4.0.

Born Mar 16, 1958.1

About

He is also the non-executive chairman of the pharmaceutical company Ipsen since 2010. He is on the board of Claris Bio, a Harvard Ophthalmology spin-off.

From Wikipedia’s article on Marc de Garidel, shared under CC BY-SA 4.0.2

Companies

  • IpsenChief executive officer Nov 2010 to Jul 18, 20163

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3